12. November 2009 03:40
Allos Therapeutics, Inc. today announced that abstracts from studies of FOLOTYN™ (pralatrexate injection) were accepted for presentation at the 51st Annual Meeting of the American Society of Hematology (ASH) to be held at the Ernest N. Morial Convention Center in New Orleans, La., from December 5-8, 2009.
[More]
87523b52-325b-41d2-8ea6-e7a68f41d2c3|0|.0
Posted in: Medical Condition News | Pharmaceutical News
Tags: Anemia, Bone, Bone Marrow, Cancer, Cell, Dehydration, Dyspnea, Folic Acid, Gemcitabine, Hematology, Lymphoma, Nausea, Neutropenia, Nursing, Prophylaxis, Sepsis, Stem Cell, Thrombocytopenia, Transplant
10. November 2009 01:46
MicroDose Therapeutx Inc. (formerly MicroDose Technologies) today announced that it has acquired a portfolio of compounds for the potential treatment of respiratory syncytial virus (RSV) from ViroPharma Incorporated (Exton, PA). The lead investigational compound in the portfolio is an inhalable small molecule fusion inhibitor, now called MDT-637.
[More]
6. November 2009 03:48
"My three year old had a skin breakout we think was due to eggs - is it safe to do a flu shot?" It's a question being asked to every doctor who takes care of kids during flu season. "On the one hand we are concerned about the devastating effects of the new strain of flu, and on the other we aren't sure if a history of eggs sensitivity is enough to hold the shot or spray," said Bobby Q. Lanier, M.D., clinical professor of pediatrics at the University of North Texas HSC in Fort Worth, Texas, and executive medical director of the American College of Allergy, Asthma and Immunology (ACAAI).
[More]
d380d676-bcad-44e4-9980-9e6163511cc4|0|.0
Posted in: Disease/Infection News | Pharmaceutical News
Tags: Allergy, Asthma, Education, H1N1, Hospital, Immunology, Influenza, Pediatrics, Prophylaxis, Vaccine, Virus
5. November 2009 07:51
Inspire Pharmaceuticals, Inc. announced today financial results for the third quarter ended September 30, 2009, reporting a net loss of $8.5 million or ($0.12) per common share.
[More]
ff0c7387-a177-416c-977e-4d9cc2329121|0|.0
Posted in: Business / Finance
Tags: Antibiotic, Azithromycin, Conjunctivitis, Cyclosporine, Cystic Fibrosis, Dry Eye, Erythromycin, Fibrosis, Glaucoma, Hospital, Prophylaxis
4. November 2009 04:18
ThromboGenics NV, a biopharmaceutical company focused on innovative medicines for eye disease, vascular disease and cancer, is today issuing a business update for the period ending 30 September, 2009.
[More]
38fd0fb4-bd4d-4ee9-902f-7c8e2ef872d6|0|.0
Posted in: Business / Finance | Drug Trial News
Tags: Antibody, Biotechnology, Cancer, Diabetes, Diabetic Macular Edema, Diabetic Retinopathy, Edema, Exercise, Monoclonal Antibody, Orthopedic, Prophylaxis, Thrombosis
2. November 2009 07:35
Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the treatment and prevention of infectious and progressive respiratory diseases, today announced that it has been awarded a grant for $2.2 million from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), aimed at advancing the development of novel influenza therapeutics for the treatment of seasonal and pandemic influenza.
[More]
3b89e21f-37ee-41f6-a12b-dcaa5e2ec2a3|0|.0
Posted in: Drug Trial News | Disease/Infection News
Tags: Allergy, Asthma, Biotechnology, Cystic Fibrosis, Fibrosis, H1N1, Influenza, Pandemic, Pathology, Pneumonia, Prophylaxis, Toxicology, Ventilator, Virus
31. October 2009 02:57
MedImmune announced today it will present four abstracts at the 47th Annual Meeting of Infectious Disease Society of America (IDSA) being held here October 29 through November 1, 2009. These abstracts advance the body of data surrounding respiratory syncytial virus (RSV) and influenza prevention, highlighting MedImmune's leadership in pediatric health.
[More]
8a6c9d90-ad6a-496d-bcb0-113026ed1138|0|.0
Posted in: Child Health News | Disease/Infection News
Tags: Antibiotic, Antibody, Arginine, Aspirin, Asthma, Biotechnology, Hypersensitivity, Immunization, Influenza, Monoclonal Antibody, Pneumonia, Prophylaxis, Sore Throat, Vaccine, Virus
29. October 2009 05:31
Research and Markets(http://www.researchandmarkets.com/research/4cc738/commercial_insight) has announced the addition of the "Commercial Insight: Anticonvulsants - Non-epilepsy Label Expansions Provide Blockbuster Potential" report to their offering.
[More]
29. October 2009 04:02
Recent news articles regarding the scarcity of the "flu shot" (or influenza inoculations) have been widespread. The shortage of the material, due to manufacturing and regulatory issues, has led to increased interest in homeopathic Influenzinum.
[More]
29. October 2009 02:00
Recent news articles regarding Swine Flu H1N1 have been widespread. The virulence of the strain among humans and its implications for pandemic disease in humans may lead to increased interest in homeopathic treatments for Swine Flu H1N1.
[More]
1c67bd2d-a6d2-4f56-ae02-a16ce1c71c00|0|.0
Posted in: Disease/Infection News | Pharmaceutical News
Tags: Cough, Diarrhea, Education, H1N1, Headache, Pandemic, Prescription Drug, Prophylaxis, Sore Throat, Swine Flu, Vomiting
28. October 2009 07:38
Several new guidelines and position papers offering the most up to date information to ensure that clinicians practice evidence-based medicine were released at the Canadian Cardiovascular Congress 2009 this week.
[More]
4d2705ef-4661-4dc3-aca1-deb50e6e89bd|0|.0
Posted in: Healthcare News
Tags: Anemia, Antibiotic, Atherosclerosis, Atrial Fibrillation, Biopsy, Cardiology, Cardiovascular Disease, Cholesterol, Contraception, Diabetes, Dyslipidemia, Genetics, Healthy Living, Heart Failure, Physiology, Pregnancy, Prophylaxis, Psychiatry, Pulmonary Hypertension, Stroke
28. October 2009 03:36
ThromboGenics NV and co-development partner BioInvent International announce that they have completed recruitment of their Phase II trial of TB-402 ahead of schedule.
[More]
6a0e2336-4286-4b1e-aa0a-3ed17223e206|0|.0
Posted in: Drug Trial News | Pharmaceutical News
Tags: Antibody, Arthritis, Atherosclerosis, Biotechnology, Blood Clot, Cancer, Hip Replacement, Monoclonal Antibody, Prophylaxis, Pulmonary Embolism, Rheumatism, Thrombosis
28. October 2009 01:45
NovaDel Pharma Inc., has entered into a licensing agreement with privately-held Mist Acquisition, LLC to manufacture and commercialize the NitroMist® lingual spray version of nitroglycerine, a widely-prescribed and leading short-acting nitrate for the treatment of angina pectoris.
[More]
e6b5577c-56f4-4b9f-bec1-0368a2775d78|0|.0
Posted in: Business / Finance | Pharmaceutical News
Tags: Angina, Biotechnology, Cardiomyopathy, Congestive Heart Failure, Coronary Artery Disease, Exercise, Headache, Heart Failure, Insomnia, Metabolism, Migraine, Nausea, Posture, Prophylaxis
27. October 2009 06:04
Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced issuance of Japanese Patent Number: 4354633, titled, "Hypoxia regulated genes," on August 7, 2009.
[More]
32e8098b-6256-4e92-8a7c-ce7519f72d1f|0|.0
Posted in: Medical Science News | Medical Patent News
Tags: Angiogenesis, Apoptosis, Blood Vessel, Brain, Diabetic Macular Edema, Edema, Hypoxia, Macular Degeneration, Pfizer, Prophylaxis, siRNA, VEGF
23. October 2009 00:42
After discussion with the Public Health Agency of Canada, and based on the evidence for other adjuvanted vaccines as well as experience around the world to date with the adjuvanted H1N1 vaccine, Canadian experts say that both the adjuvanted and non-adjuvanted H1N1 vaccines are safe for pregnant women.
[More]
44428a5e-8fa0-4502-b365-db582cb3be77|0|.0
Posted in: Women's Health News | Pharmaceutical News
Tags: Education, Gynaecology, H1N1, H5N1, Influenza, Obstetrics, Pandemic, Pregnancy, Prophylaxis, Vaccine, Virus, Vitamin E
Subscribe